首页|贝复舒联合普拉洛芬治疗白内障超声乳化术后角膜水肿的疗效及对视力的影响

贝复舒联合普拉洛芬治疗白内障超声乳化术后角膜水肿的疗效及对视力的影响

扫码查看
目的 探讨重组牛碱性成纤维细胞生长因子滴眼液(商品名:贝复舒)、普拉洛芬共同应用在白内障超声乳化术后角膜水肿患者中的疗效及对其视力的影响.方法 选取 96 例白内障超声乳化术后角膜水肿患者,按照随机法进行分组,分别为对照组、观察组,各 48 例.对照组患者单独应用普拉洛芬治疗,观察组同时应用贝复舒、普拉洛芬开展治疗.比较两组患者的治疗效果、视力情况、生活质量、不良反应发生率.结果 观察组总有效率 91.67%比对照组的 75.00%高,差异有统计学意义(P<0.05).治疗后 1、4、12 周,观察组的视力分别为(0.06±0.07)、(0.05±0.06)、(0.04±0.06),均优于对照组的(0.13±0.11)、(0.09±0.09)、(0.08±0.11),差异有统计学意义(P<0.05).治疗后,观察组的社会、情绪、躯体、认知、角色功能评分分别为(81.72±20.34)、(89.89±18.56)、(81.45±22.46)、(89.79±14.12)、(89.57±28.46)分,高于对照组的(69.12±22.29)、(78.36±14.24)、(67.37±14.61)、(80.64±19.53)、(74.42±18.27)分,差异有统计学意义(P<0.05).观察组患者不良反应发生率 4.17%与对照组的 8.33%比较,差异无统计学意义(P>0.05).结论 贝复舒、普拉洛芬共同应用在白内障超声乳化术后角膜水肿患者中,能够帮助患者改善视力,有效促进其早日康复,值得临床上推广使用.
Efficacy of recombinant bovine basic fibroblast growth factor eye drops combined with pranoprofen on corneal edema after cataract phacoemulsification surgery and its influence on visual acuity
Objective To explore the efficacy of recombinant bovine basic fibroblast growth factor eye drops combined with pranoprofen on corneal edema after cataract phacoemulsification surgery and its influence on visual acuity.Methods A total of 96 patients with corneal edema after phacoemulsification surgery were randomly divided into a control group and an observation group,with 48 cases in each group.The control group was treated with pranoprofen alone,while the observation group was treated with recombinant bovine basic fibroblast growth factor eye drops and praprofen simultaneously.The treatment effect,visual acuity,quality of life and incidence of adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 91.67%,which was higher than the control group's 75.00%,and the difference was statistically significant(P<0.05).At 1,4 and 12 weeks after treatment,the visual acuity of the observation group were(0.06±0.07),(0.05±0.06)and(0.04±0.06)points,which were better than(0.13±0.11),(0.09±0.09)and(0.08±0.11)points in the control group,and the difference was statistically significant(P<0.05).After treatment,the social,emotional,physical,cognitive and role function scores of the observation group were(81.72±20.34),(89.89±18.56),(81.45±22.46),(89.79±14.12)and(89.57±28.46)points,which were higher than(69.12±22.29),(78.36±14.24),(67.37±14.61),(80.64±19.53)and(74.42±18.27)points of the control group.The difference was statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the observation group(4.17%)and the control group(8.33%)(P>0.05).Conclusion The combined application of recombinant bovine basic fibroblast growth factor eye drops and praloprofen in patients with corneal edema after cataract phacoemulsification can help patients improve vision and effectively promote their early recovery,which is worthy of clinical promotion.

Recombinant bovine basic fibroblast growth factor eye dropsPranoprofenCataractPhacoemulsification surgeryCorneal edemaVisual acuity indicatorsTreatment effect

解娜、王民

展开 >

271500 东平县中医院药剂科

贝复舒 普拉洛芬 白内障 超声乳化术 角膜水肿 视力指标 治疗效果

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(10)